We are live on ! Find out more
SURG

SYNERGETICS USA, INC.

Delisted

SURG was delisted on the 15th of October, 2015.

59 hedge funds and large institutions have $35.4M invested in SYNERGETICS USA, INC. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

4% more funds holding

Funds holding: 5759 (+2)

26% less capital invested

Capital invested by funds: $47.5M → $35.4M (-$12.1M)

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
1.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
21
Reduced
11
Closed
6
Calls
Puts
Net Calls
Net Calls Change

SURG Hedge Fund Activity: Q1 2014 in Review

59 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in SYNERGETICS USA, INC. (SURG) for Q1 2014, worth a combined $35.4M — down 26% from $47.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SURG positions and 6 closed out — a net gain of 4 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was Royce & Associates, adding an estimated $1.73M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $3.2M sold.

  • 59 institutional investors held SYNERGETICS USA, INC. (SURG) as of Q1 2014, up from 57 in Q4 2013.
  • Funds reported $35.4M of SYNERGETICS USA, INC. stock for Q1 2014, down 26% quarter-over-quarter.
  • 10 funds opened new SYNERGETICS USA, INC. positions in Q1 2014 and 6 closed out, a net change of +4 holders.
  • The largest SYNERGETICS USA, INC. buyer in Q1 2014 was Royce & Associates, an estimated $1.73M added.
  • The largest SYNERGETICS USA, INC. seller in Q1 2014 was Raymond James & Associates, an estimated $3.2M sold.

Based on aggregated 13F filings for Q1 2014.